Pfizer: erinevus redaktsioonide vahel

Eemaldatud sisu Lisatud sisu
PResümee puudub
P liigendus, {{IPA|...
28. rida:
}}
[[file:Pfizerworldheadquartersentrance.jpg|pisi|Peakorter New Yorgis|250px]]
'''Pfizer Inc.''' (hääldus [{{IPA|ˈfaɪzər]}})<ref name=Longman /> on [[Ameerika Ühendriigid|Ameerika Ühendriikides]] asuv [[ravim]]i<nowiki>firma</nowiki> peakorteriga [[New York|New Yorgis]].
{{pooleli}}
 
2020. aasta 9. novembril teatas ettevõtte esindaja dr Bill Gruber saavutustest [[COVID-19|koroona]][[vaktsiin]]i väljatöötamisel.<ref name=AP />
 
==Välislingid==
* Sarah Boseley ja Philip Oltermann, [https://www.theguardian.com/world/2020/nov/09/covid-19-vaccine-candidate-effective-pfizer-biontech Covid-19 vaccine candidate is 90% effective, says Pfizer], [[TheGuardian.com]], 9. november 2020
 
==Viited==
41. rida ⟶ 38. rida:
<ref name=AP>{{cite web|url=https://apnews.com/article/pfizer-vaccine-effective-early-data-4f4ae2e3bad122d17742be22a2240ae8 |title=Pfizer says COVID-19 vaccine is looking 90% effective |trans-title= |publisher=[[Associated Press|AP News]] |date=9. november 2020, 19:00 |access-date=9.11.2020 |website=apnews.com |language=en |author1=Linda A. Johnson|author2=Lauran Neergaard|quote=“We’re in a position potentially to be able to offer some hope,” Dr. Bill Gruber, Pfizer’s senior vice president of clinical development, told The Associated Press. “We’re very encouraged.”}}</ref>
}}
 
==Välislingid==
* Sarah Boseley ja Philip Oltermann, [https://www.theguardian.com/world/2020/nov/09/covid-19-vaccine-candidate-effective-pfizer-biontech Covid-19 vaccine candidate is 90% effective, says Pfizer], [[TheGuardian.com]], 9. november 2020
 
[[Kategooria:Ameerika Ühendriikide ettevõtted]]